# Nebivolol in Patients With Systolic Stage 2 Hypertension

> **NCT01057251** · PHASE4 · COMPLETED · sponsor: **Forest Laboratories** · enrollment: 433 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01057251
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-12
- **Final completion:** 2011-01
- **Target enrollment:** 433 (ACTUAL)
- **Last updated:** 2012-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01057251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01057251, "Nebivolol in Patients With Systolic Stage 2 Hypertension". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01057251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*